<SEC-DOCUMENT>0001558370-18-000077.txt : 20180109
<SEC-HEADER>0001558370-18-000077.hdr.sgml : 20180109
<ACCEPTANCE-DATETIME>20180109163030
ACCESSION NUMBER:		0001558370-18-000077
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180108
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180109
DATE AS OF CHANGE:		20180109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AxoGen, Inc.
		CENTRAL INDEX KEY:			0000805928
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				411301878
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36046
		FILM NUMBER:		18519422

	BUSINESS ADDRESS:	
		STREET 1:		13631 PROGRESS BLVD.
		STREET 2:		SUITE 400
		CITY:			ALACHUA
		STATE:			FL
		ZIP:			32615
		BUSINESS PHONE:		(386) 462-6817

	MAIL ADDRESS:	
		STREET 1:		13631 PROGRESS BLVD.
		STREET 2:		SUITE 400
		CITY:			ALACHUA
		STATE:			FL
		ZIP:			32615

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LECTEC CORP /MN/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8-k.htm
<DESCRIPTION>8-K
<TEXT>
<!--HTML document created with Merrill Bridge  7.3.329.0-->
<!--Created on: 1/9/2018 2:30:20 PM-->
<html>
	<head>
		<title>
			axgn_CurrentFolio_8K
		</title>
	</head>
	<body><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p style="margin:0pt;border-top:3pt solid #000000 ;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 1pt;">
			<font style="display:inline;font-size:1pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt solid #000000 ;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 12pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 12pt;">
			<font style="display:inline;">UNITED STATES</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">SECURITIES AND EXCHANGE COMMISSION</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">Washington, D.C. 20549</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 16pt;">
			<font style="display:inline;font-size:16pt;">Form 8-K</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 12pt;">
			<font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-weight:bold;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">Current Report</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:10pt;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of&nbsp;1934</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">Date of Report (Date of earliest event reported): January 8, 2018</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-weight:bold;font-size: 16pt;">
			<font style="display:inline;font-size:16pt;">AXOGEN, INC</font><font style="display:inline;">.</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">(</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Exact name of registrant as specified in its charter)</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:31.38%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">Minnesota</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.10%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:35.60%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">001-36046</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.10%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:28.84%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">41-1301878</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:31.38%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">(State or other jurisdiction of</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.10%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:35.60%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">(Commission&nbsp;File&nbsp;Number)</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.10%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:28.84%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">(IRS Employer Identification&nbsp;No.)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:31.38%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">incorporation)</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:02.10%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:35.60%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:02.10%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:28.84%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:50.22%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">13631 Progress Boulevard, Suite 400,</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.14%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:47.64%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.22%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">Alachua,&nbsp;Florida </font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.14%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:47.64%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">32615</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:50.22%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">(Address of Principal&nbsp;Executive&nbsp;Offices)</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:02.14%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:47.64%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">(Zip Code)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Registrant&#x2019;s telephone number, including area code</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:100.00%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">(386) 462-6800</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:100.00%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">(Former name or former address if changed since last report,)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-size:9pt;">&#x2610;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;Written&nbsp;communications&nbsp;pursuant&nbsp;to&nbsp;Rule&nbsp;425&nbsp;under&nbsp;the&nbsp;Securities&nbsp;Act&nbsp;(17&nbsp;CFR&nbsp;230.425)</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-size:9pt;">&#x2610;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;Soliciting&nbsp;material&nbsp;pursuant&nbsp;to&nbsp;Rule&nbsp;14a-12&nbsp;under&nbsp;the&nbsp;Exchange&nbsp;Act&nbsp;(17&nbsp;CFR&nbsp;240.14a-12)</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-size:9pt;">&#x2610;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-size:9pt;">&#x2610;</font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#xA7;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#xA7;240.12b-2 of this chapter).</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Emerging growth company </font><font style="display:inline;color:#000000;font-size:9pt;">&#x2610;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </font><font style="display:inline;color:#000000;font-size:9pt;">&#x2610;</font>
		</p>
		<p style="margin:0.05pt 0pt 0pt;border-bottom:1pt solid #000000 ;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-bottom:3pt solid #000000 ;font-family:Calibri;font-size: 1pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:1pt;">&nbsp;</font>
		</p>
		<p style="margin:0.2pt 0pt 0pt;font-family:Calibri;font-size: 5pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:5.5pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 11pt;">
			&nbsp;
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;font-family:Calibri;font-size: 11pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">Item 2.02 Results of Operations and Financial Condition</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">On January 8, 2018, AxoGen, Inc. (the &#x201C;Company&#x201D;) issued a press release announcing its estimated fourth quarter and full year 2017 revenue. A copy of the press release is furnished as Exhibit 99.1 to this Current Report.</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">The information furnished pursuant to Item 2.02 of this Current Report, including Exhibit 99.1 hereto, shall not be considered &#x201C;filed&#x201D; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#x201C;Exchange Act&#x201D;), or otherwise subject to the liability of such section, nor shall it be incorporated by reference into future filings by the Company under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly sets forth in such future filing that such information is to be considered &#x201C;filed&#x201D; or incorporated by reference&nbsp;therein.</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">Item 9.01. Financial Statements and Exhibits</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:15.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;height:1.00pt;overflow:hidden;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">P</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:83.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:15.00%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Exhibit&nbsp;No.</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:83.00%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:15.00%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">99.1</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:02.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:83.00%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">AxoGen, Inc. Press Release, dated January 8,&nbsp;2018.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 7pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:7pt;"></font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;font-family:Calibri;font-size: 11pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">EXHIBIT INDEX</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:15.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:83.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:15.00%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Exhibit&nbsp;No.</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:83.00%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:15.00%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">99.1</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:02.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:83.00%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<a href="ex-99d1.htm"><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">AxoGen, Inc. Press Release, dated January 8,&nbsp;2018.</a></font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;"></font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 11pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;font-family:Calibri;font-size: 11pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:9pt;">SIGNATURE</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Calibri;font-size: 9pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font>
		</p>
		<p style="margin:0pt;font-family:Calibri;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:49.98%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:50.02%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">AXOGEN, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:49.98%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:50.02%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:49.98%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Date: January&nbsp;9,&nbsp;2018</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">By: </font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:47.16%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">/s/ Gregory&nbsp;G.&nbsp;Freitag</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:49.98%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:47.16%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Gregory G.&nbsp;Freitag</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:49.98%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:02.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:47.16%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">General Counsel &amp; Senior VP of Business</font></p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:49.98%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:02.86%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:47.16%;padding:0pt;">
					<p style="margin:0pt;font-family:Calibri;font-size: 9pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:9pt;">Development</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Calibri;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:10pt;">&nbsp;</font>
		</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex-99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Merrill Bridge  7.3.329.0-->
<!--Created on: 1/9/2018 2:30:19 PM-->
<html>
	<head>
		<title>
			axgn_Ex99_1
		</title>
	</head>
	<body><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p style="margin:0pt;text-align:right;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;color:#000000;font-size:11pt;">Exhibit&nbsp;99.1</font>
		</p>
		<p style="margin:0pt;text-align:right;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;"><img src="ex-99d1g001.jpg" style="width: 2.127388in; height: 0.6775525in" alt="axogen-inc-logo.jpg"></font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:14pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">AxoGen, Inc.&nbsp;Preannounces&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:14pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">Estimated Fourth Quarter and Full Year 2017&nbsp;Revenue</font>
		</p>
		<p style="margin:0pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:14pt;display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:normal;font-style:italic;color:#000000;font-size:11pt;">Q4 Revenue will be at least&nbsp;$16.5&nbsp;million, representing 45% growth over prior year</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:14pt;display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:normal;font-style:italic;color:#000000;font-size:11pt;">2017 Revenue will be at least &nbsp;$60.0&nbsp;million, representing 46% growth over prior year</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">ALACHUA, FL &#x2013; January&nbsp;8, 2018 &#x2013; </font><font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">AxoGen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, &nbsp;today announced preliminary unaudited fourth quarter and&nbsp;full year 2017&nbsp;revenue and selected business highlights&nbsp;for the quarter and year ended December 31, 2017.</font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;color:#000000;">Preliminary&nbsp;Revenue and Selected Business Highlights</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:left;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;font-size:11pt;text-align:left;border-bottom:1pt none #D9D9D9;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:left;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">Fourth quarter revenue is expected to be&nbsp;at least&nbsp;$16.5&nbsp;million, up 45% compared to the fourth quarter of 2016&nbsp;revenue of $11.4 million </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:left;border-top:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;font-size:11pt;text-align:left;border-top:1pt none #D9D9D9;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:left;border-top:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">Full year 2017 revenue is expected to be&nbsp;at least &nbsp;$60.0&nbsp;million, up 46% compared to 2016 revenue of $41.1&nbsp;million</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;font-size:11pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">Ended the quarter with 60&nbsp;direct sales representatives and 20 independent distributors&nbsp;</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;font-size:11pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">Completed 15 national education programs in 2017 and expect to conduct 18&nbsp;programs in 2018</font></p></td></tr></table></div>
		<p style="margin:0pt;text-align:left;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">&#x201C;We are pleased to report another successful quarter and a solid finish to 2017,&#x201D; said Karen Zaderej, president and CEO of AxoGen. &#x201C;These results reflect the strength of our growing platform for nerve repair where we see continued momentum in our core trauma, nerve protection and oral and maxillofacial markets. We enter 2018 with an expanding sales force that will allow us to continue growth in our core markets while also supporting our newest application in breast reconstruction neurotization.&#x201D;</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;color:#000000;font-size:11pt;">2017 Financial Guidance </font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">Management increases its full year 2017 revenue guidance to at least $60.0 million. Management reiterates its full year 2017 gross margin guidance to exceed 80%.</font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;color:#000000;font-size:11pt;">2018 Financial Guidance </font>
		</p>
		<p style="margin:0pt;text-align:left;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">Management reiterates 2018 annual revenue will grow at least 40% over 2017 revenue and gross margins will remain above 80%.&nbsp;&nbsp; </font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;color:#000000;font-size:11pt;">Upcoming Investor Event </font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:left;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;text-align:left;border-bottom:1pt none #D9D9D9;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:left;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">Members of the AxoGen senior management team will participate in The Trout Group Annual 1-on-1 Management Access Event in San Francisco, January 8&#x2013;10, 2018. To request a meeting, please contact </font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">axogenevents@troutgroup.com</font><font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">.&nbsp; </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt;">
			<p style="text-align:left;border-top:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;text-align:left;border-top:1pt none #D9D9D9;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-size:11pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:left;border-top:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;margin:0pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">AxoGen will also participate in the Leerink 7</font><font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:6pt;top:-4pt;position:relative;line-height:100%">th</font><font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;"> Annual Global Healthcare Conference in New York City, February 14, 2018. </font></p></td></tr></table></div>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;text-align:left;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">The results disclosed in this press release are preliminary and unaudited. The Company will report full, audited results for the fourth quarter and year ended December 31, 2017&nbsp;on February 28,&nbsp;2018.</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;color:#000000;font-size:11pt;">About AxoGen</font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">AxoGen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about helping to restore nerve function and quality of life to patients with peripheral nerve injuries by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Peripheral nerves provide the pathways for both motor and sensory signals throughout the body. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves.&nbsp;Damage to a peripheral nerve can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. </font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">AxoGen's platform for nerve repair features a comprehensive portfolio of products, including Avance</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;font-size:6pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;"> Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;font-size:6pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;"> Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves, AxoGuard</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;font-size:6pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;"> Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments, and Avive</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;font-size:6pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">&nbsp;Soft Tissue Membrane, a minimally processed human umbilical cord membrane that may be used as a resorbable soft tissue covering to separate tissue layers and modulate inflammation in the surgical bed. Along with these core surgical products, AxoGen also offers AcroVal</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;font-size:6pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;"> Neurosensory &amp; Motor Testing System and AxoTouch</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;font-size:6pt;top:-4pt;position:relative;line-height:100%">&#xAE;</font><font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;"> Two-Point Discriminator. These evaluation and measurement tools assist health care professionals in detecting changes in sensation, assessing return of sensory, grip, and pinch function, evaluating effective treatment interventions, and providing feedback to patients on nerve function. The AxoGen portfolio of products is available in the United States, Canada, the United Kingdom, and several other European and international countries.</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;color:#000000;font-size:11pt;">Cautionary Statements Concerning Forward-Looking Statements</font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">This Press Release contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations or predictions of future conditions, events, or results based on various assumptions and management's estimates of trends and economic factors in the markets in which we are active, as well as our business plans. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "projects," "forecasts," "continue," "may," "should," "will," and variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements may include, without limitation, statements regarding our assessment on our internal control over financial reporting, our growth, our 2017 and 2018 guidance, product development, product potential, financial performance, sales growth, product adoption, market awareness of our products, data validation, our visibility at and sponsorship of conferences and educational events. The forward-looking statements are subject to risks and uncertainties, which may cause results to differ materially from those set forth in the statements. Forward-looking statements in this release should be evaluated together with the many uncertainties that affect AxoGen's business and its market, particularly those discussed in the risk factors and cautionary statements in AxoGen's filings with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those projected once audited financial statement are finalized. The forward-looking statements are representative only as of the date they are made and, except as required by law, AxoGen assumes no responsibility to update any forward-looking statements, whether as a result of new information, future events, or otherwise.</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;background-color: #FFFFFF;text-align:left;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;font-weight:bold;color:#000000;">Contacts:</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">AxoGen, Inc.</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">Peter J. Mariani, Chief Financial Officer</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">InvestorRelations@AxoGenInc.com</font><font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">The Trout Group &#x2013; Investor Relations </font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">Brian Korb </font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;">646.378.2923</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;color:#000000;font-size:11pt;">bkorb@troutgroup.com</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;color:#000000;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Arial,Helvetica,sans-serif;font-size:12pt;">&nbsp;</font>
		</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex-99d1g001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex-99d1g001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" "5 =0# 2(  A$! Q$!_\0
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M8L/DE5=9VBOF]?P3/H_"?+7B^):#MI3YIOY*R_\ )FCZRHHHK^:S^T HHHH
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M*6EF/]I\<MZ*N6/IC)'U/\&O^"5.B_#[26\2?%OQ!9BSL4\^>QMIS#:Q*/\
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M/$.M74/EZIXR<7[DCYEMP"(%^A4LX_ZZU^\\4<01R?!?6$DY-I16U^_R2O\
M@?RKP+PG/B+,_JDI.,$G*4EJTMEOU;:^5WT/SZ_X9A^)7_1//'/_ ((;K_XW
M1_PS#\2O^B>>.?\ P0W7_P ;K]EZ*_-O^(K8O_GQ'[V?L_\ Q ? ?]!4_P#P
M&)^(OC#P%KOP\U&.S\0:+JVAW<T8F2#4+.2UD="2 P5P"5R",],@UDU]A?\
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M2*>#D H _.S]MCX(R>#?VUM4TCRVBL_%6I17]HV,!TNI/FQ])3(O_ :^I/\
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M9;ON^[?5O5A1116)T!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
:444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
